Efficacy and safety of cerivastatin, a novel potent HMG-CoA reductase inhibitor, in primary hypercholesterolaemia: A comparative study

被引：0
|
作者：
Leiter, LA [1 ]
机构：
[1] ST MICHAELS HOSP,TORONTO,ON M5B 1W8,CANADA
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
10.1016/S0021-9150(97)88696-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：128 / 129
页数：2
相关论文
共 50 条
  • [41] Simvastatin: In Vitro Metabolic Profiling of a Potent Competitive HMG-CoA Reductase Inhibitor
    Yin, Wencui
    Alwabli, Reem I.
    Attwa, Mohamed W.
    Rahman, A. F. M. Motiur
    Kadi, Adnan A.
    SEPARATIONS, 2022, 9 (12)
  • [42] Pitavastatin: The Newest HMG-CoA Reductase Inhibitor
    Watson, Karol E.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2010, 11 (01) : 28 - 34
  • [43] Pitavastatin: A New HMG-CoA Reductase Inhibitor
    Wensel, Terri M.
    Waldrop, Bruce A.
    Wensel, Brian
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 507 - 514
  • [44] SYNTHESIS OF L-669,262, A POTENT HMG-COA REDUCTASE INHIBITOR
    STOKKER, GE
    JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (20): : 5983 - 5986
  • [45] HMG-CoA reductase inhibitor cerivastatin prolonged rat cardiac allograft survival by blocking intercellular signals
    Horimoto, H
    Nakai, Y
    Nakahara, K
    Nomura, Y
    Mieno, S
    Sasaki, S
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (04): : 440 - 445
  • [46] HMG-CoA reductase inhibitor cerivastatin inhibits interleukin-6 expression and secretion in human adipocytes
    van Harmelen, V
    Skurk, T
    Röhrig, K
    Hauner, H
    HORMONE AND METABOLIC RESEARCH, 2003, 35 (08) : 466 - 470
  • [47] NK-104: a novel synthetic HMG-CoA reductase inhibitor
    Kajinami, K
    Mabuchi, H
    Saito, Y
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (11) : 2653 - 2661
  • [48] Comparative tolerability of the HMG-CoA reductase inhibitors
    Farmer, JA
    Torre-Amione, G
    DRUG SAFETY, 2000, 23 (03) : 197 - 213
  • [49] Comparative Tolerability of the HMG-CoA Reductase Inhibitors
    John A. Farmer
    Guillermo Torre-Amione
    Drug Safety, 2000, 23 : 197 - 213
  • [50] Effects of cerivastatin sodium, a new HMG-CoA reductase inhibitor, on biliary lipid metabolism in patients with hypercholesterolemia
    Tazuma, S
    Yamashita, G
    Ochi, H
    Miura, H
    Kajihara, T
    Hattori, Y
    Miyake, H
    Nishioka, T
    Hyogo, H
    Sunami, Y
    Yasumiba, S
    Kajiyama, G
    CLINICAL THERAPEUTICS, 1998, 20 (03) : 477 - 485
12345